InceptionR’s Guardant Health GH Stock Holding History

InceptionR’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18M	Buy	12,762 +6,029	+90%	+$605K	0.28%	102
2025 Q4	$688K	Sell	6,733 -3,993	-37%	-$357K	0.19%	194
2025 Q3	$670K	Buy	+10,726	New	+$583K	0.16%	226

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

InceptionR's GH Position: Q1 2026 in Review

InceptionR increased its Guardant Health (GH) stake by 90% in Q1 2026, buying an estimated $605K and bringing the position to 12,762 shares worth $1.18M. The position accounts for 0.28% of the portfolio, ranked #102.

InceptionR first reported a position in GH in Q3 2025 and has held it in 3 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

InceptionR held 12,762 shares of Guardant Health worth $1.18M as of Q1 2026.
InceptionR bought 6,029 Guardant Health shares in Q1 2026, an estimated $605K.
Guardant Health made up 0.28% of InceptionR's portfolio in Q1 2026, its #102 holding.
InceptionR first reported a position in Guardant Health in Q3 2025 and has held it in 3 quarters since.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.